Authors
Latest:
Patient Characteristics and Healthcare Utilization of a Chronic Pain Population Within an Integrated Healthcare SystemThis study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Latest:
Ambulatory Care–Sensitive Emergency Visits Among Patients With Medical Home AccessPatients often self-refer to the emergency department (ED) for management of an ambulatory care–sensitive condition, and the ED may be the most appropriate care location.
Latest:
Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid PatientsAmong HIV-positive Medicaid patients with comorbid medical and psychiatric disorders, there was increased outpatient service utilization, yet relative cost savings, for patients who were treated in patient-centered medical homes.
Latest:
Disease Management Programs: Barriers and BenefitsPerceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.
Latest:
Care Transition Management and Patient Outcomes in Hospitalized Medicare BeneficiariesHospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.
Latest:
Impact of Workplace Health Services on Adherence to Chronic MedicationsPatients who used workplace primary care and pharmacy services had higher adherence rates to medications for their chronic conditions than community-treated patients.
Latest:
Impact of Hypertension on Healthcare Costs Among ChildrenThis study demonstrates a major influence of prehypertension and hypertension on healthcare costs in a large cohort of children, independent of body mass index.
Latest:
Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient DetoxificationThe mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
Latest:
Adherence, Persistence, and Switching Patterns of Dabigatran EtexilateWe present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Latest:
Characteristics of Home-Based Care Provided by Accountable Care OrganizationsAccountable care organizations (ACOs) deliver a diverse array of home-based services, but many of the services are not reimbursed. ACOs may not expand these programs without strong evidence of cost savings.
Latest:
Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory SettingPilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.
Latest:
Medicaid Prior Authorization and Opioid Medication Abuse and OverdoseEnrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.
Latest:
Medical Care Costs Among Patients With Established Cardiovascular DiseaseThe economic burden of providing care to patients with cardiovascular disease, driven by secondary hospitalizations, may be substantially greater than current American Heart Association estimates.
